Immutep IMMP
NASDAQ IMMP
$0.36 -0.01 (-2.66%)
At close: Sep 9, 2026 · 4:00 PM EDT

Immutep (IMMP) Current Leases (2019 - 2026)

Immutep's (IMMP) quarterly Current Leases came in at $537247.9 in Q2 2026, up 166.38% on a YoY basis from $201681.4 in Q2 2025, and down 13.83% quarter-over-quarter from $623485.4 in Q4 2025.

Analysis

Immutep (IMMP) Current Leases (2019 - 2026) Analysis & Trends

Immutep (IMMP) has reported Current Leases for 8 consecutive years, with $537247.9 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Current Leases rose 166.38% year-over-year to $537247.9; the trailing twelve-month figure through Jun 2026 stood at $537247.9 (up 166.38% YoY), and the FY2026 full-year result was $537247.9, up 166.38% from the prior year.
  • Current Leases declined to $537247.9 in Q2 2026 per IMMP's latest filing, from $623485.4 in the prior quarter.
  • Across five years, Current Leases topped out at $623485.4 in Q4 2025 and bottomed at $23059.5 in Q4 2022.
  • Historically, Current Leases has averaged $272241.0 across 5 years, with a median of $255726.5 in 2024.
  • The sharpest annual moves came in 2022 and 2023: Current Leases tumbled 71.24% in 2022, then jumped 1331.05% in 2023.
  • Over 5 years, Current Leases stood at $23059.5 in 2022, then surged by 1331.05% to $329992.3 in 2023, then slipped by 22.51% to $255726.5 in 2024, then soared by 143.81% to $623485.4 in 2025, then dropped by 13.83% to $537247.9 in 2026.
  • According to Business Quant data, Current Leases over the past three periods registered $537247.9, $623485.4, and $201681.4 for Q2 2026, Q4 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn -
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn 720.00 Mn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn 11.00 Mn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn 45.93 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn -
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn 12.38 Mn
10 Immutep 51.68 Mn 51.68 Mn - 537,247.89
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 537,247.89
Dec 31, 2025 623,485.44
Jun 30, 2025 201,681.38
Dec 31, 2024 255,726.46
Jun 30, 2024 263,220.31
Dec 31, 2023 329,992.28
Jun 30, 2023 138,762.99
Dec 31, 2022 23,059.49
Jun 30, 2022 76,993.11
Dec 31, 2021 80,178.79
Jun 30, 2021 61,691.43
Dec 31, 2020 67,858.52
Jun 30, 2020 87,151.94
Dec 31, 2019 98,573.23